119 related articles for article (PubMed ID: 11064661)
1. Extensive soft tissue uptake of 99Tcm methylene diphosphonate in a patient with multiple myeloma.
Evans JC; Murphy M; Eyes B
Br J Radiol; 2000 Sep; 73(873):1018-20. PubMed ID: 11064661
[TBL] [Abstract][Full Text] [Related]
2. Absent skeletal uptake of (99m)Tc-hydroxymethylene diphosphonate in the presence of AL-type amyloidosis associated with multiple myeloma.
Sasaki T; Okizaki A; Takahashi K; Mineta M; Nagasawa K; Fujimoto Y; Kohda K; Aburano T
Jpn J Radiol; 2011 Oct; 29(8):595-7. PubMed ID: 21928004
[TBL] [Abstract][Full Text] [Related]
3. Non-osseous bone scan abnormalities in multiple myeloma associated with hypercalcemia.
Eagel BA; Stier SA; Wakem C
Clin Nucl Med; 1988 Dec; 13(12):869-73. PubMed ID: 3246115
[TBL] [Abstract][Full Text] [Related]
4. Extraosseous soft tissue uptake-in Multiple Myeloma.
Mir KB; Fatima S; Batool S; Marwat N; Faheem M; Ammar A
J Pak Med Assoc; 2022 Jul; 72(7):1454-1455. PubMed ID: 36156583
[TBL] [Abstract][Full Text] [Related]
5. Soft-tissue uptake of technetium-99m MDP in multiple myeloma.
Kanoh T; Uchino H; Yamamoto I; Torizuka K
Clin Nucl Med; 1986 Dec; 11(12):878-9. PubMed ID: 3815990
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of renal-skeleton ratio of technetium-99m phosphonate in multiple myeloma.
Dey HM; Karimeddini MK; Spencer RP; Sziklas JJ
J Nucl Med; 1985 Nov; 26(11):1270-4. PubMed ID: 4056922
[TBL] [Abstract][Full Text] [Related]
7. Increased uptake of technetium-99m methylene diphosphonate in muscles in the course of polymyositis.
Niemir Z; Oleksa R; Czepczyński R; Sowiński J
Nucl Med Rev Cent East Eur; 2005; 8(2):153-4. PubMed ID: 16437405
[TBL] [Abstract][Full Text] [Related]
8. Increased technetium-99 m hydroxy diphosphonate soft tissue uptake on bone scintigraphy in chronic kidney disease patients with secondary hyperparathyroidism: correlation with hyperphosphataemia.
Enevoldsen LH; Heaf J; Højgaard L; Zerahn B; Hasbak P
Clin Physiol Funct Imaging; 2017 Mar; 37(2):131-136. PubMed ID: 26148143
[TBL] [Abstract][Full Text] [Related]
9. Extraosseous uptake of Tc-99m methylene diphosphonate in the pectoralis muscles 8 days after exercise.
Groell R; Aigner R
Clin Nucl Med; 2000 Jan; 25(1):65-6. PubMed ID: 10634541
[No Abstract] [Full Text] [Related]
10. Pentavalent technetium-99m-DMSA uptake in a patient having multiple myeloma without amyloidosis.
Ohnishi T; Noguchi S; Murakami N; Tajiri J; Morita M; Tamaru M; Hoshi H; Watanabe K
J Nucl Med; 1991 Sep; 32(9):1785-7. PubMed ID: 1652629
[TBL] [Abstract][Full Text] [Related]
11. Technetium-99m-methylene disphosphonate (MDP) bone scan hypercalcemia.
Basoglu T; Canbaz F; Bernay I
J Nucl Med; 1998 Dec; 39(12):2034, 5A. PubMed ID: 9867137
[No Abstract] [Full Text] [Related]
12. Bone scintigraphy in the diagnosis of pulmonary calcification in multiple myeloma.
Morassi P; Paladini G; Mazzanti G; Cataldo R; Cantalupi D; Versari A
Eur J Nucl Med; 1985; 11(8):327-9. PubMed ID: 4076242
[TBL] [Abstract][Full Text] [Related]
13. Myocardial, pulmonary, and gastric uptake of technetium-99m MDP in a patient with multiple myeloma and hypercalcemia.
Reitz MD; Vasinrapee P; Mishkin FS
Clin Nucl Med; 1986 Oct; 11(10):730. PubMed ID: 3769329
[No Abstract] [Full Text] [Related]
14. Diffuse hepatic uptake of (99m)Tc methylene diphosphonate on bone scintigraphy in a case of hypercalcemia and diffuse large B cell lymphoma.
Qiu ZL; Xue YL; Song HJ; Luo QY
Hell J Nucl Med; 2013; 16(1):66-7. PubMed ID: 23789120
[No Abstract] [Full Text] [Related]
15. Technetium-99m-sestamibi scintigraphy in multiple myeloma and related gammopathies: a useful tool for the identification and follow-up of myeloma bone disease.
Balleari E; Villa G; Garrè S; Ghirlanda P; Agnese G; Carletto M; Clavio M; Ferrando F; Gobbi M; Mariani G; Ghio R
Haematologica; 2001 Jan; 86(1):78-84. PubMed ID: 11146575
[TBL] [Abstract][Full Text] [Related]
16. Discordant uptake on Ga-67 and Tc-99m MDP scintigraphy in a patient with multiple myeloma: an indication of poor prognosis.
Li T; Farinhas J; Chun KJ; Freeman LM
Clin Nucl Med; 2003 Apr; 28(4):322-4. PubMed ID: 12642716
[No Abstract] [Full Text] [Related]
17. Marked soft tissue uptake of bone tracer in a patient with amyloidosis and multiple myeloma.
Posch TJ; Olson SP
Clin Nucl Med; 1992 Nov; 17(11):909. PubMed ID: 1424388
[No Abstract] [Full Text] [Related]
18. Altered radiopharmaceutical distribution in myeloma: bone tracer in the heart and heart tracer in the bone.
Gupta AK; Meyer P; Gross MD; Fig LM; Shapiro B
Clin Nucl Med; 1998 Dec; 23(12):820-3. PubMed ID: 9858293
[TBL] [Abstract][Full Text] [Related]
19. What is the value of Tc-99m hydroxymethylene diphosphonate scintigraphy for the etiological diagnosis of mild rhabdomyolysis?
Esnault VL; Nakhla M; Delcroix C; Moutel MG; Couturier O
Clin Nucl Med; 2007 Jul; 32(7):519-23. PubMed ID: 17581334
[TBL] [Abstract][Full Text] [Related]
20. Detection of focal myeloma lesions by technetium-99m-sestaMIBI scintigraphy.
Catalano L; Pace L; Califano C; Pinto AM; De Renzo A; Di Gennaro F; Del Vecchio S; Fonti R; Salvatore M; Rotoli B
Haematologica; 1999 Feb; 84(2):119-24. PubMed ID: 10091409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
